Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DEPOCYT

CYTARABINE

Standard Dose
10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DEPOCYT is listed in Drugs@FDA under application 021041 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CYTARABINE Form and strength INJECTABLE, LIPOSOMAL;INJECTION - 10MG/ML Sponsor PACIRA PHARMS INC Submission history Latest submission status date: 2017-01-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview DEPOCYT is listed in Drugs@FDA under application 021041 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYTARABINE Form and strength INJECTABLE, LIPOSOMAL;INJECTION - 10MG/ML Sponsor PACIRA PHARMS INC Submission history Latest submission status date: 2017-01-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.